• High-Throughput BBB Permeability Modeling with LLC-PK1-MDR1

  2026-06-03

  This article reviews a 2025 study that introduces an in vitro surrogate blood-brain barrier (BBB) model using LLC-PK1-MOCK/MDR1 cells and lysosomal trapping correction for high-throughput CNS drug screening. The model's predictive accuracy and practical advantages for early-stage drug metabolism and permeability research are discussed.

• Ionomycin Calcium Salt: Precision Calcium Ionophore for Cell

  2026-06-03

  Ionomycin calcium salt enables robust, reproducible modulation of intracellular Ca2+—empowering advanced research in apoptosis, protein synthesis, and oncology. This guide translates the latest mechanistic insights and troubleshooting strategies into actionable protocols for maximizing experimental clarity and data reliability.

• Ciclesonide in Respiratory Research: Mechanistic Insights &

  2026-06-02

  Explore the advanced pharmacology and targeted mechanism of Ciclesonide in respiratory disease research. This article uniquely analyzes desisobutyryl-ciclesonide’s potency, ER-associated degradation, and translational strategies for asthma and allergic rhinitis.

• Direct Mouse Genotyping Kit Plus: Optimizing Cardiovascular

  2026-06-02

  Discover how the Direct Mouse Genotyping Kit Plus streamlines mouse genotyping for advanced atherosclerosis and macrophage studies. This article explores protocol optimization, technical insights, and new frontiers in cardiovascular research.

• Necrosulfonamide: Precision Tool for Necroptosis Pathway Res

  2026-06-01

  Necrosulfonamide (NSA) empowers researchers to dissect necroptosis with unmatched specificity by selectively inhibiting MLKL translocation. This article details optimized experimental workflows, troubleshooting guidance, and translational use-cases for NSA, positioning it as a cornerstone in cardiovascular, cancer, and neurodegenerative disease modeling.

• Lenalidomide (CC-5013): Mechanisms, Evidence, and Benchmarks

  2026-06-01

  Lenalidomide (CC-5013) is an oral thalidomide derivative acting as an antineoplastic agent through immune activation, angiogenesis inhibition, and direct tumor cell targeting. This article details its molecular mechanisms, benchmarks for experimental use, and clarifies its validated scope in multiple myeloma research.

• EdU Imaging Kits (Cy3): Precision S-Phase DNA Synthesis Dete

  2026-05-31

  EdU Imaging Kits (Cy3) empower researchers to sensitively and reliably quantify cell proliferation via denaturation-free, click chemistry DNA synthesis measurement. This kit accelerates workflows in fluorescence microscopy and flow cytometry, providing robust alternatives to BrdU and unlocking advanced applications in genotoxicity and cell cycle research.

• EdU Imaging Kits (Cy3): Decoding S-Phase Dynamics in Stem an

  2026-05-30

  Discover how EdU Imaging Kits (Cy3) enable advanced, high-fidelity measurement of S-phase DNA synthesis, unlocking new insights into stem and progenitor cell dynamics. This in-depth article explores the unique technical and biological advantages of EdU-based assays for developmental and regenerative research.

• Spatial Transcriptomics Reveals Cortical Neuron Vulnerabilit

  2026-05-29

  This study uses spatial transcriptomics to pinpoint which cortical neurons are most susceptible to Lewy pathology in Parkinson’s disease and elucidates a conserved molecular dysfunction signature. These findings deepen our understanding of disease progression and highlight new directions for mechanistic research in neurodegeneration.

• Nilotinib (AMN-107): Precision Workflows for Kinase Research

  2026-05-29

  Nilotinib (AMN-107) enables robust dissection of BCR-ABL and KIT-driven signaling in chronic myeloid leukemia and gastrointestinal stromal tumor models. This guide translates recent mechanistic findings and best practices into actionable workflows, troubleshooting tips, and advanced applications to maximize reproducibility and translational impact.

• Applied Losartan Workflows: Angiotensin II Receptor Antagoni

  2026-05-28

  Losartan, a potent angiotensin II receptor antagonist, empowers researchers to dissect cardiovascular and tumor microenvironment mechanisms with precision. Discover advanced experimental workflows, troubleshooting strategies, and applied innovations—including nanohydrogel delivery—driving breakthroughs in hypertension and immunomodulation studies.

• Bismuth Subsalicylate in Gastrointestinal Disorder Research

  2026-05-28

  Bismuth Subsalicylate, a high-purity prostaglandin G/H synthase inhibitor, is redefining experimental workflows in gastrointestinal and inflammation research. This article details robust protocol enhancements, practical troubleshooting strategies, and the translational value of membrane biology insights for advanced GI disorder models.

• Lipo3K Transfection Reagent: Precision Gene Delivery in Resi

  2026-05-27

  Uncover how Lipo3K Transfection Reagent enables high-efficiency nucleic acid delivery—even in drug-resistant and difficult-to-transfect cell types. This article offers novel scientific insights and practical workflow strategies beyond standard protocols.

• Hypoxia and Immunometabolism in Tumor Microenvironment: Mech

  2026-05-27

  Wu et al. (2025) present a comprehensive review of how hypoxia-driven metabolic reprogramming and immune cell adaptation underpin the immunosuppressive tumor microenvironment (TME). Their synthesis highlights the intertwined roles of oxygen deprivation, metabolic competition, and immune escape, informing future strategies for tumor-targeted therapies.

• M344: Precision Epigenetic Modulation in Cancer & HIV Latenc

  2026-05-26

  Explore how M344, a potent histone deacetylase inhibitor, enables precise epigenetic modulation for advanced cancer and HIV latency research. This article uniquely dissects mechanistic subtleties, solubility challenges, and workflow integration, offering guidance distinct from prior literature.

14890 records 1/993 page Next 12345 下5页 Last page